Clinical Trial Update: Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial evaluating desvenlafaxine succinate for vasomotor symptoms in menopausal women, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vasomotor Symptoms

Drugs mentioned

• Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

Sponsor: Pfizer | Conditions: Vasomotor Symptoms | Phase 3 | Status: COMPLETED | Results posted: 2011-08-17